206 related articles for article (PubMed ID: 8690587)
1. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
Hoshi M; Matsuura M; Hayakawa N; Ito C; Kamada N
Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
[TBL] [Abstract][Full Text] [Related]
2. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
[TBL] [Abstract][Full Text] [Related]
3. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
4. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
Otake M; Schull WJ
J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
[TBL] [Abstract][Full Text] [Related]
5. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
Otake M; Schull WJ
Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
[TBL] [Abstract][Full Text] [Related]
6. Reassessment of the cancer mortality risk among Hiroshima atomic-bomb survivors using a new dosimetry system, ABS2000D, compared with ABS93D.
Katayama H; Matsuura M; Endo S; Hoshi M; Ohtaki M; Hayakawa N
J Radiat Res; 2002 Mar; 43(1):53-64. PubMed ID: 12056330
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University.
Matsuura M; Hoshi M; Hayakawa N; Shimokata H; Ohtaki M; Ikeuchi M; Kasagi F
Int J Radiat Biol; 1997 May; 71(5):603-11. PubMed ID: 9191905
[TBL] [Abstract][Full Text] [Related]
8. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
Kosako T
J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Impact of a New Computational Voxel Phantom Series for the Japanese Atomic Bomb Survivors: Methodological Improvements and Organ Dose Response Functions.
Sato T; Funamoto S; Paulbeck C; Griffin K; Lee C; Cullings H; Egbert SD; Endo A; Hertel N; Bolch WE
Radiat Res; 2020 Oct; 194(4):390-402. PubMed ID: 33045092
[TBL] [Abstract][Full Text] [Related]
10. Fetal atomic bomb survivor dosimetry using the J45 series of pregnant female phantoms with realistic survivor exposure scenarios: comparisons to dose estimates in the DS02 system.
Paulbeck CJ; Sato T; Funamoto S; Lee C; Griffin KT; Cullings HM; Egbert SD; Endo A; Hertel NE; Bolch WE
Radiat Environ Biophys; 2023 Aug; 62(3):317-329. PubMed ID: 37296237
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
Ishimaru T; Otake M; Ischimaru M
Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
[No Abstract] [Full Text] [Related]
12. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
Stram DO; Mizuno S
Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
[TBL] [Abstract][Full Text] [Related]
14. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
Gilbert ES; Ohara JL
Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
[TBL] [Abstract][Full Text] [Related]
15. Recent uses of biological data for the evaluation of A-bomb radiation dosimetry.
Stram DO; Sposto R
J Radiat Res; 1991 Mar; 32 Suppl():122-35. PubMed ID: 1762098
[TBL] [Abstract][Full Text] [Related]
16. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
Shimizu Y; Kato H; Schull WJ
Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
[TBL] [Abstract][Full Text] [Related]
17. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
18. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
Preston DL; Pierce DA
Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
[TBL] [Abstract][Full Text] [Related]
19. Prospects and status of the dosimetry system for atomic bomb survivor cohort study conducted at Research Institute for Radiation Biology and Medicine of Hiroshima University.
Hirota S; Yasuda H; Kawakami H; Yoshinaga S
J Radiat Res; 2021 May; 62(Supplement_1):i107-i113. PubMed ID: 33978168
[TBL] [Abstract][Full Text] [Related]
20. Leukemia: lessons from the Japanese experience.
Finch SC
Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
